234107-95-0 Usage
Uses
Used in Pharmaceutical Industry:
5-Iodo-2-Methoxy-3-Methylpyridine is used as a synthetic intermediate for the development of pharmaceuticals, contributing to the creation of new drugs and improving existing ones.
Used in Agrochemical Industry:
In the agrochemical sector, 5-Iodo-2-Methoxy-3-Methylpyridine serves as a key intermediate in the synthesis of various agrochemicals, aiding in the production of effective pesticides and other agricultural chemicals.
Used in Chemical Research and Development:
5-Iodo-2-Methoxy-3-Methylpyridine is utilized in chemical research and development for exploring its reactivity and potential applications in creating new organic compounds and specialty chemicals.
Used in Specialty Chemicals Production:
5-Iodo-2-Methoxy-3-Methylpyridine is employed in the production of specialty chemicals, where its unique properties and reactivity are leveraged to develop high-value products for specific applications.
Due to its hazardous nature and strong reactivity, 5-Iodo-2-Methoxy-3-Methylpyridine requires careful handling and storage to ensure safety in its various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 234107-95-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,4,1,0 and 7 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 234107-95:
(8*2)+(7*3)+(6*4)+(5*1)+(4*0)+(3*7)+(2*9)+(1*5)=110
110 % 10 = 0
So 234107-95-0 is a valid CAS Registry Number.
234107-95-0Relevant academic research and scientific papers
Substituted oxoazaheterocyclyl compounds
-
Page/Page column 75, (2008/06/13)
This invention is directed to oxoazaheterocycyl compounds which inhibit Factor Xa, to oxoazaheterocycyl compounds which inhibit both Factor Xa and Factor IIa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds, to a method of directly inhibiting Factor Xa and to a method of simultaneously directly inhibiting Factor Xa and Factor IIa..
